Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014338 |
| CAS No | NA |
| Mol.F. | C35H34F2N9O6S : H2SO4 |
| Mol.Wt. | 746.8 : 98.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014339 |
| CAS No | NA |
| Mol.F. | C17H24N4O6S |
| Mol.Wt. | 412.5 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014341 |
| CAS No | NA |
| Mol.F. | C17H17N3O7 |
| Mol.Wt. | 375.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014342 |
| CAS No | NA |
| Mol.F. | C9H12N2O4 |
| Mol.Wt. | 212.20 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014343 |
| CAS No | NA |
| Mol.F. | C15H21FN4O4 |
| Mol.Wt. | 340.4 |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014344 |
| CAS No | NA |
| Mol.F. | C23H28N6O9S |
| Mol.Wt. | 564.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014345 |
| CAS No | NA |
| Mol.F. | C15H13F3N4O5S2 |
| Mol.Wt. | 450.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014346 |
| CAS No | NA |
| Mol.F. | C17H26N2O5 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014347 |
| CAS No | 2892260-31-8 |
| Mol.F. | C20H27N3O6S |
| Mol.Wt. | 437.5 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N014348 |
| CAS No | 3028194-83-1 |
| Mol.F. | C17H20N2O2 |
| Mol.Wt. | 284.35 g/mol |
| INV STATUS | In Stock |
| CAT No | SRC-N014349 |
| CAS No | 2504-18-9 |
| Mol.F. | C5H12N2O |
| Mol.Wt. | 116.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014350 |
| CAS No | 5432-28-0 |
| Mol.F. | C7H14N2O |
| Mol.Wt. | 142.2 |
| INV STATUS | In Stock |
| CAT No | SRC-N014351 |
| CAS No | NA |
| Mol.F. | C16H16N4O |
| Mol.Wt. | 280.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014352 |
| CAS No | NA |
| Mol.F. | C13H23N5O4S |
| Mol.Wt. | 345.4 |
| INV STATUS | In Stock |
| CAT No | SRC-N014353 |
| CAS No | 59469-02-2 |
| Mol.F. | C18H14ClFN4O |
| Mol.Wt. | 356.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014354 |
| CAS No | 64605-07-8 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 |
| INV STATUS | CUSTOM SYNTHESIS |